April 2017
April Adverse Events Report: FDA Labeling Changes
April 21, 2017
Article
Adverse Events Report
The adverse events report featuring FDA labeling changes for bendamustine hydrochloride, nilotinib, dinutuximab.
Everyone's Business: Taking Survivorship Care to the Next Level
April 20, 2017
Article
Cover Story
The ever-growing number of cancer survivors means that practitioners across the healthcare spectrum need to step up to an active and dynamic role in their care.
Capturing the Patient's Voice: Reporting Cancer Treatment Toxicities in Clinical Trials
April 19, 2017
Article
Partner Perspectives
The voice of the patient during clinical trials must be captured, to fully record the impact of treatment toxicity and symptoms.
Phase III Trial to Examine Veliparib in BRCA Positive Breast Cancer
April 19, 2017
Article
Clinical Trials in Progress
An ongoing trial is evaluating the addition of PARP inhibitor velaparib to a chemotherapy combination, for patients with HER2-negative, germline BRCA-associated metastatic or locally advanced breast cancer.
New Safety Requirements for Nurses Handling Antineoplastic Agents
April 17, 2017
Article
Feature Story
Nurses may think that if they are careful, their routine drug administration activities will not result in hazardous drug leaking and exposure, but even small leaks are problematic.
"Scanxiety": Helping Patients Cope
April 14, 2017
Article
Nurse's Notes
Patients with cancer know all too well the worry that accompanies waiting for test results. What can healthcare providers do to help?
The Universal Language of Caring
April 13, 2017
Article
Nurse Navigators
Language barriers can mean patients put off preventive screenings, and even treatment, for fear of being misunderstood by their healthcare providers.
Fast Facts for the Frontline: Oral Care and Mucositis During Cancer Treatment
April 12, 2017
Article
Fast Facts for the Frontline
Many anticancer therapies increase the risk of oral mucositis, leading to dose reduction or treatment delays. There are interventions that can help, and more are under study.